scispace - formally typeset
C

Carlo M. Croce

Researcher at Ohio State University

Publications -  1156
Citations -  199822

Carlo M. Croce is an academic researcher from Ohio State University. The author has contributed to research in topics: microRNA & Cancer. The author has an hindex of 198, co-authored 1135 publications receiving 189007 citations. Previous affiliations of Carlo M. Croce include University of Nebraska Medical Center & University of California, Los Angeles.

Papers
More filters
Journal ArticleDOI

A novel fully human anti-NCL immunoRNase for triple-negative breast cancer therapy.

TL;DR: In this article, a novel immunoRNase constituted by 4LB5 and a human pancreatic RNase (HP-RNase) was developed for triple negative breast cancer.
Patent

Materials and Methods Related to Modulation of Mismatch Repair and Genomic Stability by miR-155

TL;DR: In this paper, materials and methods related to modulation of mismatch and genomic stability by miR-155 were presented, and the miR155 was used to solve the problem of genomic instability.
Journal Article

The Human ALL-1/MLL/HRX Antigen Is Predominantly Localized in the Nucleus of Resting and Proliferating Peripheral Blood Mononuclear Cells

TL;DR: The anti-ALL1-N serum reacted with a polypeptide corresponding to the expected full-length 430-kDa ALL-1 protein, which probably is a DNA-binding protein with both a sequence-unspecific (AT-hook) and a sequences-specific (zinc binding subdomains) double-stranded DNA binding mode.
Journal ArticleDOI

Chromosomal approaches to oncogenes and oncogenesis.

TL;DR: In this paper, the effects of chromosome translocations in B and T cell lymphomas and in chronic myelogenous leukemia have demonstrated the effects on protooncogenes of transposition within the genome, with or without structural change in the gene.
Journal ArticleDOI

A Novel Ultrasensitive Hybridization-Based ELISA Method for 2-Methoxyphosphorothiolate MicroRNAs and Its In vitro and In vivo Application

TL;DR: An ultrasensitive and selective assay for quantification of synthetic 2′-methoxyphosphorothiolate-miRNA in mouse plasma and cell lysate for the first time is developed and validated and concludes that this method provides a general and valuable tool for the pharmacologic study and clinical development of synthetic miRNAs.